The company is focused primarily on developing tools to analyze clinical samples, and is targeting applications such as non-invasive prenatal diagnostics, circulating tumor cells and tumor progression, and infectious disease.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.